• Quotes
  • Shortcuts
The Executive's Internet
Tues, May 24th



Setup News Ticker
Searching for 'Stocks S'. (Return)

Washington Post BusinessMay 24, 2022
Inflation, rate hike fears push stocks lower in up-and-down trading
The Dow falls more than 200 points while the S&P 500 threatens to cross into a bear market.

INmune Bio stock plunges after clinical hold of IND of Alzheimer's treatment prompts analyst downgrade (MarketWatch MarketPulse)

Yahoo BusinessMay 24, 2022
Billionaire George Soros just loaded up on these two beaten-down growth stocks

The Tell: $250 billion in ‘rebalancing' inflows could rescue stocks by the end of June, JPMorgan says (MarketWatch)

CNBC FinanceMay 24, 2022
Stocks making the biggest moves in the premarket: Best Buy, Abercrombie & Fitch, Snap and more
The stocks making the biggest moves in premarket trading include Best Buy, Abercrombie & Fitch, Snap, and more.

Best Buy beats on revenue, lowers guidance (MarketWatch MarketPulse)

Washington Post BusinessMay 24, 2022
Stocks poised for a downturn as Wall Street's wild ride continues
Wall Street pointed to another sell-off as S&P 500 remains close to bear territory.

Yahoo BusinessMay 24, 2022
Social Media Stocks Set to Erase $100 Billion on Snap Warning

MarketWatch MarketPulseMay 24, 2022
Petco shares rise after earnings and sales beat
Petco Health & Wellness Co. Inc. shares rose 4.5% in Tuesday premarket trading after it reported first-quarter profit and revenue that beat expectations. The company posted net income of $24.7 million, or 9 cents per share, up from $7.6 million, or 3 cents per share, last year. Adjusted EPS of 17 cents beat the FactSet consensus for 15 cents. Revenue of $1.476 billion was up from $1.415 billion last year and ahead of the FactSet consensus for $1.450 billion. Comparable sales growth was 5.1%, beating the FactSet consensus for 2.8% growth. Petco maintained its fiscal year guidance for net revenue of $6.15 billion to $6.25 billion and adjusted EPS of 97 cents to $1. The FactSet consensus is for revenue of $6.194 billion and EPS of 99 cents. Petco stock is down 26.2% for the year to date while the S&P 500 index is down 16.6% for the period.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

MarketWatch MarketPulseMay 24, 2022
UPDATE: Internet stocks slide premarket as Snap's profit warning sends stock down 30%
A slew of internet stocks were sharply lower premarket Tuesday, caught up in the wave of selling sparked by Snap Inc.'s warning late Monday that second-quarter earnings would lag estimates. Snap CEO Evan Spiegel issued the warning at a JP Morgan technology conference, and the company filed it with the SEC. Spiegel said that the economy has "definitely deteriorated further and faster" than Snap SNAP, -3.40% had expected when it gave its forecast during its earnings call last month. He added that the Snapchat parent is slowing its hiring pace for the year and looking for ways to cut costs. Snap shares fell 30%, Meta Platforms Inc. was down 7%, Alphabet Inc. was down 3.5%, Pinterest Inc. was down 13%, Twitter Inc. was down 3.6% and Amazon.com Inc. was down 2%. Netflix Inc. fell 1.6%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

MarketWatch MarketPulseMay 24, 2022
AutoZone stock rallies after earnings beat, surprise increase in same-store sales
Shares of AutoZone Inc. rose 1.1% in premarket trading Tuesday, after the automotive replacement parts retailer reported fiscal third-quarter earnings that rose above expectations and surprise growth in same-store sales, citing strength in both retail and commercial sales. Net income for the quarter to May 7 was $592.6 million, or $29.03 a share, after earnings of $596.2 million, or $26.48 a share, in the year-ago period, as the weighted average number of diluted shares outstanding declined 9.3% to 20.41 million. The FactSet consensus was for earnings per share of $26.18. Sales grew 5.9% to $3.87 million, above the FactSet consensus of $3.71 billion, while same-store sales growth of 2.6% beat expectations of a 0.1% decline. Cost of sales increased 7.1% to $1.86 billion, as gross margin contracted to 51.9% from 52.4%. The company spent $900 million to repurchase 449,000 shares during the quarter. The stock has lost 13.9% year to date through Monday, while the S&P 500 has declined 16.6%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

Yahoo BusinessMay 24, 2022
In a ‘baby with the bathwater' market, here are a dozen unfairly punished stocks, ripe for a bounce

Stock market news live updates: Futures point to continued losses after stocks close higher (Yahoo Business)

MarketWatch MarketPulseMay 24, 2022
Dole shares slide 3% premarket after food distributor swings to Q1 loss and revenue falls short of estimates
Dole PLC shares slid 3% in premarket trade Tuesday, after the distributor of fruit and vegetables swung to a loss for the first quarter and posted revenue that fell short of estimates. Dole posted a net loss of $1.4 million, or 1 cent a share, for the quarter, after income of $21.3 million, or 38 cents a share, in the year-earlier period. Adjusted per-share earnings came to 30 cents, ahead of the 27 cent FactSet consensus. Revenue rose to $2.245 billion from $1.051 billion a year ago, below the $2.324 billion FactSet consensus. "We are pleased with the result that the Group has delivered for the first quarter of 2022 particularly as we were impacted by the Value Added salads recall and foreign currency translation movements in the quarter," CEO Carl McCann said in a statement. The recall and currency moves shaved $112 million off revenue in the quarter, he said. The company is now expecting full-year revenue to range from $9.4 billion to $9.7 billion, compared with a FactSet consensus of $9.7 billion. Shares have fallen 16% in the year to date, while the S&P 500 has fallen 16.6%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

MarketWatch MarketPulseMay 24, 2022
Coronavirus tally: FDA advisory panel to meet June 15 to discuss Pfizer, BioNTech and Moderna vaccines for children aged 6 months to 4 years
The Food and Drug Administration said Monday an advisory panel would meet June 15 to discuss use of the vaccines developed by Pfizer Inc. and German partner BioNTech SE as well as the one developed by Moderna Inc. in children aged 6 months to four years old. The announcement came after Pfizer and BioNTech said three doses of their vaccine proved 80% effective at preventing symptomatic infections in children in that cohort. If the panel adopts a positive opinion on the shots, the FDA could authorize them by as soon as June 16 or 17, bringing relief to parents of children who will finally be eligible for vaccination. COVID cases continue to rise across the U.S. and trend at the highest levels seen since March, driven by the BA.2 variant of omicron, and two other subvariants that appear to be even more infectious. The U.S. is averaging 107,316 cases a day, up 46% from two weeks ago, according to a New York Times tracker. The country is averaging 24,747 hospitalizations a day, up 28% from two weeks ago. The daily death toll has fallen to 312 on average, down 15% from two weeks ago. Cases are higher in nearly every state, but the Northeast and Midwest are being particularly hard hit with case reports in both regions now higher than they were at the peak of last summer's delta surge. There are concerns that case numbers are even higher, as many people are now testing at home and the data is not being collected. On a global basis, total cases are now above 5256 million. Total deaths are above 6.27 million, according to data aggregated by Johns Hopkins University, with the U.S. still leading the way with 83.4 million cases and 1,002,377 deaths.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

MarketWatchMay 24, 2022
The Tell: When will stocks find a bottom? Treasury yields need a footing first, says this strategist
It's ‘Finance 101 stuff' that Treasury yields need to stabilize before it's possible to gauge if U.S. equities have hit bottom, according to DataTrek Research.

Entrepreneur.comMay 24, 2022
Cheap Buys: These 3 Stocks are Now Trading Under $20
These three long-term winners have dipped to levels that make them attractive buys.

Google Business NewsMay 23, 2022
Dow Jones Futures Fall, Tech Futures Sell Off As Snap Crashes 30% On Q2 Warning - Investor's Business Daily
Dow Jones Futures Fall, Tech Futures Sell Off As Snap Crashes 30% On Q2 Warning  Investor's Business DailyAsia stocks slip with US futures, euro holds gains By Reuters  Investing.comS&P Futures Show Speculation on End-Of-Day Gains  BarchartStocks, Futures Decline on China Angst, Tech Slide: Markets Wrap  Yahoo Canada FinanceAsian markets under pressure amid concerns over inflation, rising rates  ANC 24/7View Full Coverage on Google News

USA Today MoneyMay 23, 2022
Americans were 'doing okay' or 'living comfortably' last fall before inflation hit, stocks plunged
Seventy-eight percent of adults were 'doing ok' or 'living comfortably' last fall, highest on record, Fed survey shows.     

The Motley FoolMay 23, 2022
Why Cruise Stocks Like Carnival and Norwegian Sank Today
An analyst cuts his price targets on the two prominent cruise line companies.

Why Moderna and Pfizer Stocks Lagged the Market Today (The Motley Fool)
Why Nordic American Tankers Shares Fell 21.3% Today (The Motley Fool)

CNBC FinanceMay 23, 2022
S&P 500 rises more than 1%, Dow adds 600 points as stocks try to recover from sharp sell-off
Stocks jumped Monday as the market tried to recover some of the losses from a relentless sell-off that has gripped Wall Street.

MarketWatch MarketPulseMay 23, 2022
Dow climbs more than 600 points, U.S. stocks end sharply higher as Wall Street banks jump
All three major stock benchmarks ended sharply higher Monday, kicking off the week with gains as shares in the financials sector jumped. The Dow Jones Industrial Average closed up almost 619 points, or about 2%, while the S&P 500 climbed around 1.9% and the Nasdaq Composite rose about 1.6%, according to preliminary FactSet data. The financials sector booked the biggest gains in the S&P 500 index, rising around 3.2% Monday, as Wall Street banks JPMorgan Chase & Co. and Citigroup Inc. each jumped around 6%, preliminary FactSet data show.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

The Motley FoolMay 23, 2022
These 2 Stocks Led the Dow Higher Monday
A nice bounce for the stock market continued Wall Street's upward momentum.

Gold closed higher Monday for third straight session (MarketWatch MarketPulse)

Yahoo BusinessMay 23, 2022
These Are The 5 Best Stocks To Buy And Watch Now

Yahoo BusinessMay 23, 2022
Snap's warning of a weaker outlook sends ripples through tech stocks

MarketWatch First Take: Snap's warning of a weaker outlook sends ripples through tech stocks (MarketWatch)

KiplingerMay 03, 2022
Bausch Lomb IPO: What You Need to Know
Bausch Lomb, a well-known leader in eye care, is about to hit Wall Street in what investment bankers almost certainly hope will jump-start a weak initial public offering (IPO) market.

Bausch Health Companies (BHC) is a global healthcare stock that develops pharmaceuticals, medical devices and over-the-counter medications, with focus areas in eye health, gastroenterology and dermatology.

SEE MORE 7 Best Biotech Stocks to Build Your Portfolio However, to help streamline its operations and pay down debt, Bausch is spinning off its Bausch Lomb eye care division in what is shaping up to be one of 2022's most anticipated IPOs.

Bausch Lomb sells contact lenses, eye drops and even implantable lenses for cataract surgery in more than 100 countries. The division boasts more than 400 products, more than 260 of which came on the market since 2017.

You can thank Bausch Lomb's robust R&D arm, which has about 850 employees. The current product pipeline includes more than 100 projects, such as treatments for dry eye, contact lenses to slow myopia, and next-gen cataract equipment.

The focus on innovation has helped to grow the top line. For 2021, division revenues jumped by 10.6% to $3.8 billion - part of BHC's overall revenues of $8.4 billion, up 5% - and the company flipped from a loss of $17 million to a net gain of $193 million.

"While it faces significant competition from other brands and generic products, the company is highly profitable with strong cash flow

stockmarket Buy Earnings Snap Dow
stocksBuy market Dow these Snap
BusinessChina How Insider Futures Airbnb
BuyStocks Stock Best Earnings These
ChinaBiden Airbnb Taiwan business defend
SalesBuy Best Earnings Stock decline
SnapWarning Stock Tech 30% Dow
EarningsStock Buy beat Nvidia Ahead
Dowstock down Stocks points futures
BidenTaiwan China Asia trip CNN

Top News (Business News)
Accounting Today
AdWeek News
Banking Business Review
Barron's This Week Magazine
Barron's Up and Down Wall Street Daily
Brad Ideas
Chicago Tribune Business News
CNBC Business
CNBC Economy
CNBC Finance
CNN/Money Real Estate News
Dismal.com: Analysis
Dismal.com: Indicators
Enterprise Application News
Forbes Headlines
Forbes Social Media News
FT.com - China, Economy & Trade
FT.com - Financial Markets
FT.com - Hedge Funds
FT.com - Telecoms
FT.com - US
Google Business News
Google Market News
HBS Working Knowledge
INSEAD Knowledge
International Tax Review
L.S. Starrett News
MarketWatch Breaking News
MarketWatch MarketPulse
McKinsey Quarterly
MSNBC.com: Business
Nielsen Trends
NonProfit Times
NPR Topics: Business
NYTimes Business
Private Equity Breaking News
Reuters Business
Reuters Company News
Reuters Money
SEC.gov Updates: News Digest
Tax Policy News
The Economist International News
The Motley Fool
USA Today Money
Wall Street Journal US Business
Wall Street Transcript
Washington Post Business
WSJ Asia
WSJ Europe
WSJ MoneyBeat
WSJ Opinion
WSJ World Markets
Yahoo Business
  • CEOExpress
  • 1 Boston Place | Suite 2600
    Boston MA 02108
  • Contact
  • As an Amazon Associate
    CEOExpress earns from
    qualifying purchases.

©1999-2022 CEOExpress Company LLC